The American Journal of Managed Care^® is issuing a call for papers on paying for curative therapies. These papers, in addition to the journal’s regular content, will be published throughout the upcoming issues of the journal.

Revolutionary medical treatments including cell and gene therapies hold the potential to cure or significantly alleviate serious disorders in disease states ranging from hematology to neurology to ophthalmology. Their introduction has brought new hope to patients and families facing these diseases but simultaneously poses significant challenges from the payer perspective—with some incurring costs of millions of dollars per course of therapy. The introduction of high-cost curative therapies can disrupt budgets and upend traditional reimbursement models for payers including government programs, insurance companies, and managed care organizations.

Click here to view the Call for Papers.